MOLFETTA, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 5.872
AS - Asia 3.517
EU - Europa 3.473
SA - Sud America 591
Continente sconosciuto - Info sul continente non disponibili 365
AF - Africa 225
OC - Oceania 33
Totale 14.076
Nazione #
US - Stati Uniti d'America 5.701
IT - Italia 1.639
SG - Singapore 1.187
CN - Cina 625
DE - Germania 584
VN - Vietnam 536
BR - Brasile 443
HK - Hong Kong 429
FI - Finlandia 289
IN - India 244
FR - Francia 180
SE - Svezia 171
BD - Bangladesh 115
RU - Federazione Russa 113
NL - Olanda 100
GB - Regno Unito 98
CA - Canada 92
UA - Ucraina 77
MA - Marocco 61
AR - Argentina 59
JP - Giappone 56
KR - Corea 55
ZA - Sudafrica 52
ID - Indonesia 46
AU - Australia 33
BG - Bulgaria 33
IQ - Iraq 32
TG - Togo 31
TR - Turchia 29
ES - Italia 28
MX - Messico 26
EC - Ecuador 24
VE - Venezuela 24
AT - Austria 21
CZ - Repubblica Ceca 20
IE - Irlanda 19
IR - Iran 18
JM - Giamaica 17
PL - Polonia 17
BE - Belgio 16
PH - Filippine 16
UZ - Uzbekistan 16
CI - Costa d'Avorio 14
PK - Pakistan 14
EG - Egitto 13
RO - Romania 13
TW - Taiwan 13
DZ - Algeria 12
KE - Kenya 12
CH - Svizzera 11
CL - Cile 11
TH - Thailandia 10
AL - Albania 9
JO - Giordania 9
SA - Arabia Saudita 9
CO - Colombia 8
NP - Nepal 8
PY - Paraguay 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
DO - Repubblica Dominicana 7
LT - Lituania 7
PE - Perù 7
AZ - Azerbaigian 6
TT - Trinidad e Tobago 6
KZ - Kazakistan 5
MY - Malesia 5
PA - Panama 5
PT - Portogallo 5
SC - Seychelles 5
BO - Bolivia 4
CR - Costa Rica 4
ET - Etiopia 4
HN - Honduras 4
IL - Israele 4
NG - Nigeria 4
BA - Bosnia-Erzegovina 3
LB - Libano 3
MU - Mauritius 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
GT - Guatemala 2
HR - Croazia 2
KG - Kirghizistan 2
KH - Cambogia 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
MT - Malta 2
NO - Norvegia 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
Totale 13.698
Città #
Ashburn 895
Singapore 622
Rome 596
San Jose 555
Fairfield 405
Hong Kong 400
Dallas 253
Milan 238
Munich 236
Woodbridge 207
Chandler 204
Ho Chi Minh City 174
Seattle 165
Santa Clara 158
Los Angeles 154
Houston 151
Dearborn 146
Wilmington 136
Helsinki 131
Cambridge 127
Hanoi 127
Council Bluffs 125
Ann Arbor 121
Modena 108
Beijing 103
Hillsboro 102
Turku 89
New York 83
Frankfurt am Main 74
Princeton 74
Paris 72
Buffalo 70
Fasano 61
Lauterbourg 61
Plano 58
San Paolo di Civitate 55
The Dalles 54
Washington 50
São Paulo 48
Casablanca 47
Tokyo 46
Lawrence 43
Johannesburg 41
Boston 36
Phoenix 36
Millbury 34
Jakarta 32
Lomé 30
Sofia 30
Toronto 30
Da Nang 29
Redondo Beach 26
Montreal 25
Moscow 25
Nuremberg 24
Figino 23
Hefei 23
Jacksonville 22
London 22
Dublin 20
Naples 20
Shanghai 20
Andover 19
San Diego 19
Falkenstein 18
Haiphong 18
Chicago 17
Des Moines 17
Brussels 16
Federal 16
Guangzhou 16
Hangzhou 16
Lappeenranta 16
Rio de Janeiro 16
Tashkent 16
Boardman 15
Brooklyn 15
Cosenza 15
Orem 15
Abidjan 14
Amsterdam 14
Atlanta 14
Dhaka 14
Baghdad 13
Boydton 13
Nanjing 13
Istanbul 12
Latina 12
Biên Hòa 11
Bremen 11
Kingston 11
Norwalk 11
Prague 11
Vienna 11
Warsaw 11
Casarsa della Delizia 10
Chennai 10
Columbus 10
Falls Church 10
Fremont 10
Totale 8.698
Nome #
Immune complexes exposed on mast cell-derived nanovesicles amplify allergic inflammation 349
Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: role of HSP70/TLR2/NF-kB axis 305
Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition 278
Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells 275
Impact on NK cell functions of acute versus chronic exposure to extracellular vesicle-associated MICA. Dual role in cancer immunosurveillance 275
p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells 262
Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells. role of cMYC-IRF4-miR-125b interplay 260
The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma 257
Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms 249
The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in multiple myeloma. modulation by bromodomain and Extra-Terminal (BET) protein inhibitors 234
Bone marrow stromal cell-derived IL-8 upregulates PVR expression on multiple myeloma cells via NF-kB transcription factor 227
Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation 217
Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation 208
NKG2D down-modulation on human NK cells is followed by DNAM-1 hypo-responsivenss 202
3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells 201
Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells 194
Analysis of infiltrating MC subsets in Colorectal cancer by single-cell RNA-sequencing. 193
c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells. 192
Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production 192
CD155: a multi-functional molecule in tumor progression 190
Colorectal Cancer microenvironment controls Mast Cell phenotypical plasticity 187
Innate immune activating ligand SUMOylation affects tumor cell recognition by NK cells 184
Ubiquitin and ubiquitin-like modifiers modulate NK cell-mediated recognition and killing of damaged cells 179
Regulation of NKG2D Expression and Signaling by Endocytosis 177
SCF and IL-33 regulate intestinal mouse mast cell plasticity in colon cancer 176
Connective tissue-like Mast Cells accumulate during Colorectal Cancer progression 173
NKG2D and its ligands: one for all, all for one 172
The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway 169
Translating the anti-myeloma activity of Natural Killer cells into clinical application 169
CIN85 regulates the ligand-dependent endocytosis of the IgE receptor: A new molecular mechanism to dampen mast cell function 169
Understanding the role of mast cells in colorectal cancer progression 168
Post-translational mechanisms regulating NK cell activating receptors and their ligands in cancer: Potential targets for therapeutic intervention 163
A sustained CD16 aggregation induced by therapeutic antibody-opsonised targets impairs cytotoxic responses in human NK cells 159
New Insight into Intestinal Mast Cells Revealed by Single-Cell RNA Sequencing 155
Samhd1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity 155
NKG2D engagement on human NK cells leads to DNAM‐1 hypo‐responsiveness through different converging mechanisms 153
Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia 151
Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells 151
NK cells and interferons 151
Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions 149
NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and Metastasis 149
Negative regulation of FcepsilonRI-mediated basophil activation by the Cbl family of adaptor proteins. 149
Optimizing transfection efficiency in CAR-T cell manufacturing through multiple administrations of lipid-based nanoparticles 148
Regulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis. 147
The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway. 142
NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells 141
CIN85 controls the down-regulation of engaged FcepsilonRI providing a new molecular mechanism to dampen mast cell function 141
Syk regulates ligand-induced FcepsilonRI down-modulation and degradation in mast cells 139
Syk-dependent regulation of Hrs phosphorylation and ubiquitination upon FceRI engagement: Impact on Hrs membrane/cytosol localization 139
Regulation of fc receptor endocytic trafficking by ubiquitination. 139
Ubiquitination and endocytosis of the high affinity receptor for IgE. 137
FcεRI signaling in the modulation of allergic response: role of mast cell-derived exosomes 136
The Ubiquitin-proteasome pathway regulates Nectin2/CD112 expression and impairs NK cell recognition and killing. 135
SCF and IL-33 regulate mouse mast cell phenotypic and functional plasticity supporting a pro-inflammatory microenvironment 134
Down-regulation of the NKG2D receptor is differentially controlled by MICA and ULBP2 ligands 131
The Cbl family of ubiquitin ligases regulates FcεRI expression and mast cell activation. 130
Activation of Syk tyrosine kinase is required for c-Cbl-mediated ubiquitination of Fcepsilon RI and Syk in RBL cells. 124
PIP2-dependent regulation of Munc13-4 endocytic recycling: impact on the cytolytic secretory pathway 124
Regulation of MICB shedding from multiple myeloma cells in response to genotoxic stress. 122
The Controversial Role of Intestinal Mast Cells in Colon Cancer 119
CD16 aggregation induced by therapeutic antibody-opsonised targets impairs cytotoxic responses in human NK cells 119
CIN85 regulates the ligand-induced internalization of the high affinity receptor for IgE: a new mechanism to attenuate mast cell functions 118
Cbl Family Proteins: Balancing Fc epsilon RI-Mediated Mast Cell and Basophil Activation 118
Exploring mast cell phenotype and functions during tumor progression 117
FcepsilonRI engagement induces negative pathways that attenuate receptor-mediated mast cell signalling and functions 113
Endocitosi del recettore ad alta affinità per le IgE sui mastociti: conseguenze funzionali 113
Syk kinase activity regulates endocytosis of ubiquitinated FcεRI 112
Ubiquitination and degradation of Syk and ZAP-70 protein tyrosine kinases in human NK cells upon CD16 engagement 108
Tyrosine kinase-dependent ubiquitination of CD16 zeta subunit in human NK cells following receptor engagement. 107
Lipid raft-dependent FcepsilonRI ubiquitination regulates endocytosis of engaged receptors in mast cells 106
Syk kinase activity controls the coupling of engaged FcepsilonRI to the endocytic pathway 104
CD16 engagement induces ubiquitination and degradation of Syk and ZAP-70 tyrosine kinases in human NK cells 104
Lipid raft-dependent FcepsilonRI ubiquitination controls endocytosis of engaged receptors in mast cells 101
SCF and IL-33 regulate mouse mast cell pro-inflammatory functions during tumor progression 100
Lipid raft-dependent FcepsilonRI ubiquitination regulates receptor endocytosis through the action of ubiquitin binding adaptors. 100
NKG2D triggering hampers DNAM-1-mediated signaling in human NK cells 98
Syk kinase activity regulates endocytosis of ubiquitinated FcepsilonRI on mast cells 97
Negative signal from FcepsilonRI engagement attenuate mast-cell functions. 96
SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses 94
Exploring the dynamic of NKG2D/NKG2DL axis: A central regulator of NK cell functions 93
null 92
NKG2D receptor expression is differentially controlled by MICA e ULBP2 ligands 90
Tyrosine kinase-dependent multiubiquitination of CD16 zeta subunit in human NK cells following receptor engagement 85
REGULATION OF BCR SIGNALLING IN CHRONIC LYMPHOCITYC LEUKEMIA: ROLE OF E3 UBIQUITIN LIGASE C-CBL 84
Beyond the "Master" Role in Allergy: Insights into Intestinal Mast Cell Plasticity and Gastrointestinal Diseases 83
Negative signals from FcepsilonRI engagement attenuate receptor-mediated mast cell functions 79
Nutrient transporter pattern in CD56dim NK cells: CD16 (FcγRIIIA)-dependent modulation and association with memory NK cell functional profile 70
MICA and ULBP2 differentially regulate NKG2D cell surface expression 68
null 62
Meccanismi implicati nello spegnimento delle vie di segnalazione mediate dal recettore ad alta affinità per le IgE (FcepsilonRI) 61
Targeting RNA polymerase I to boost natural killer cell anticancer activity in multiple myeloma 58
Dysregulation of DNAM-1-Mediated NK Cell Anti-Cancer Responses in the Tumor Microenvironment 57
NGF-dependent and tissue-specific transcription of vgf is regulated by a CREB-p300 and bHLH factor interaction. 56
CD155 and Its Receptors as Targets for Cancer Therapy 56
null 45
The Gut Microbiota–Mast Cell Axis in Intestinal Homeostasis and Food Allergy Pathogenesis 35
STAT4 drives optimal expansion and transcriptional repression of type I interferon pathway in inflammatory ILC2 32
An orthotopic organoid-based model to study early CD8⁺ T cell dysfunction and immunotherapy response in colorectal cancer 19
null 19
The Ubiquitin-proteasome pathway regulates Nectin2/CD112 expression and impairs NK cell recognition and killing 6
Totale 14.071
Categoria #
all - tutte 36.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022680 0 0 102 45 93 16 22 76 57 49 97 123
2022/2023970 182 272 45 81 83 96 13 55 52 2 61 28
2023/2024854 27 66 70 84 102 199 41 38 10 89 48 80
2024/20252.660 82 54 65 140 198 304 396 146 369 150 213 543
2025/20265.573 623 299 592 439 606 322 828 336 387 578 347 216
2026/2027754 221 430 103 0 0 0 0 0 0 0 0 0
Totale 14.076